Here’s what you should know.
1. A group of angel investors supplemented funding Orthokina received from a Biomedical Catalyst award and an Industrial Challenge award.
2. Orthonika will use the funding to accelerate the implant’s biomechanical testing and to carry out a pre-clinical pilot trial.
3. Orthonika Co-Founder and CEO Mario Alberto Accardi, PhD, said in a release, “This investment demonstrates a strong endorsement of our progress in developing a novel solution for meniscus injury and allows us to cement our network of collaborators and suppliers.”
More articles on orthopedics:
Return to play, patient satisfaction high in active athletes after ACL reconstruction — 5 study insights
Dr. Jeffrey Dugas performs surgery on WWE star Braum Strowman: 4 key notes
University of Pennsylvania, Children’s Hospital of Philadelphia to study youth concussions: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
